After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine

Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence. By Rebecca Robbins and Benjamin Mueller from NYT Business https://ift.tt/2VfBdeB